Elutia (ELUT) Preferred Stock Liabilities (2019 - 2020)
Elutia (ELUT) posted Preferred Stock Liabilities of $56.6 million for Q3 2020, up 26.05% sequentially from $44.9 million in Q2 2020, and up 36.66% YoY from $41.4 million in Q4 2019.
Elutia (ELUT) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends
Elutia has reported Preferred Stock Liabilities for 2 years, with the latest figure at $56.6 million in Q3 2020.
- Quarterly Preferred Stock Liabilities rose 36.66% year-over-year to $56.6 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $56.6 million (up 36.66% YoY) and the FY2019 annual result came in at $44.4 million, changed N/A from the prior year.
- Preferred Stock Liabilities climbed to $56.6 million in Q3 2020 per ELUT's latest filing, from $44.9 million in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $56.6 million in Q3 2020 and troughed at $41.4 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Elutia | 40.75 Mn | 20.85 Mn | 1.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 56.59 Mn |
| Jun 30, 2020 | 44.90 Mn |
| Mar 31, 2020 | 44.90 Mn |
| Dec 31, 2019 | 44.45 Mn |
| Sep 30, 2019 | 41.41 Mn |